Prospective study of bone mineral density changes in aging men with or at risk for HIV infection.
OBJECTIVE
To investigate rates and predictors of change in bone mineral density (BMD) in a cohort of aging men with or at risk for HIV infection.


METHODS
A prospective cohort study among 230 HIV-infected and 159 HIV-uninfected men aged at least 49 years.


METHODS
Longitudinal analyses of annual change in BMD at the femoral neck, total hip, and lumbar spine.


RESULTS
At baseline, 46% of men had normal BMD, 42% had osteopenia, and 12% had osteoporosis. Of those men with normal BMD, 14% progressed to osteopenia and 86% continued to have normal BMD. Of the men initially with osteopenia, 12% progressed to osteoporosis and 83% continued to have osteopenia. Osteopenia incidence per 100 person-years at risk was 2.6 for HIV-uninfected men and 7.2 for HIV-infected men; osteoporosis incidence was 2.2 per 100 person-years at risk among men with osteopenia, regardless of HIV status. In multivariable analysis of annual change in BMD at the femoral neck, we found a significant interaction between heroin use and AIDS diagnosis, such that the greatest bone loss occurred with both AIDS and heroin use (adjusted predicted mean annual bone loss 0.0196 g/cm). Hepatitis C virus seropositivity was also associated with femoral neck bone loss (P = 0.04). The interaction between AIDS and heroin use also was associated with bone loss at the total hip, as was current methadone use (P < 0.01).


CONCLUSIONS
We found an association of heroin use and AIDS with BMD change, suggesting that heroin users with AIDS may be at particular risk for bone loss.
Sharma
Anjali
A
Department of Medicine, Division of Infectious Diseases, State University of New York Downstate Medical Center, Brooklyn, New York 11203, USA. anjali.sharma@downstate.edu
Flom
Peter L
PL
Weedon
Jeremy
J
Klein
Robert S
RS
D000367:Age Factors; D000375:Aging / Q000502:physiology*; D015519:Bone Density / Q000187:drug effects / Q000502:physiology*; D005272:Femur Neck / Q000187:drug effects / Q000503:physiopathology; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology*; D006615:Hip / Q000503:physiopathology; D006801:Humans; D008159:Lumbar Vertebrae / Q000187:drug effects / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000175:diagnosis / Q000453:epidemiology / Q000503:physiopathology*; D015819:Substance Abuse, Intravenous / Q000150:complications / Q000503:physiopathology*